Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Geneva, Switzerland
SEC filing record 1 source field available
Fiscal year end
31 December
Addex Therapeutics Ltd. has filed 274 SEC EDGAR filings since 24 Sep 2019

SEC filing history

Showing 126-150 of 274 matching filings.

Per page
25
Current page
6
SC 13G/A File 005-91805

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
09 Feb 2023
Reporting date
09 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91805

SC 13G/A filing

Filing date
08 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91805

SC 13G/A

Filing date
06 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
06 Feb 2023
Reporting date
06 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
19 Jan 2023
Reporting date
19 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
08 Dec 2022
Reporting date
08 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91805

GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A3

Filing date
28 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91805

SC 13D/A

Filing date
23 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-262050

424B3

Filing date
22 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-266995

424B3

Filing date
16 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
14 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91805

SC 13D/A

Filing date
09 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
03 Nov 2022
Reporting date
03 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
01 Nov 2022
Reporting date
01 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K/A File 001-39179

FORM 6-K/A

Filing date
14 Sep 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
424B3 File 333-266995

424B3

Filing date
30 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-262050

EFFECT filing

Filing date
29 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-266995

EFFECT filing

Filing date
29 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
25 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
25 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-262050

POS AM

Filing date
24 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91805

GROWTH EQUITY OPPORTUNITIES FUND IV (ADDEX THERAPEUTICS) - SCHEDULE 13D/A2

Filing date
23 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-1 File 333-266995

F-1

Filing date
19 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39179

FORM 6-K

Filing date
18 Aug 2022
Reporting date
18 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .